Dr. Harish Guddati, M.D
NPI: 1891040911
Total Payments
$1,924
2024 Payments
$424.73
Companies
12
Transactions
76
Medicare Patients
1,716
Medicare Billing
$213,808
Payment Breakdown by Category
Food & Beverage$1,834 (95.3%)
Gifts$89.99 (4.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,834 | 75 | 95.3% |
| Gift | $89.99 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $731.53 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $284.59 | 10 | $0 (2024) |
| Celgene Corporation | $265.94 | 18 | $0 (2024) |
| Gilead Sciences Inc | $250.00 | 2 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $123.57 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $100.00 | 1 | $0 (2017) |
| Boston Scientific Corporation | $40.00 | 1 | $0 (2019) |
| Shionogi Inc | $29.31 | 1 | $0 (2019) |
| Celltrion USA Inc. | $28.88 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $26.86 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $424.73 | 19 | ABBVIE INC. ($227.38) |
| 2023 | $428.99 | 25 | ABBVIE INC. ($222.33) |
| 2022 | $439.67 | 21 | ABBVIE INC. ($260.07) |
| 2021 | $87.62 | 4 | Celgene Corporation ($39.01) |
| 2019 | $69.31 | 2 | Boston Scientific Corporation ($40.00) |
| 2017 | $473.57 | 5 | Gilead Sciences Inc ($250.00) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/17/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/21/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: Neuroscience | ||||||
| 02/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Neuroscience | ||||||
| 01/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Neuroscience | ||||||
| 11/15/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/19/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: Neuroscience | ||||||
| 10/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.71 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 459 | 525 | $697,015 | $61,242 |
| 2022 | 11 | 466 | 531 | $578,828 | $60,173 |
| 2021 | 12 | 436 | 492 | $550,087 | $55,692 |
| 2020 | 11 | 355 | 393 | $385,994 | $36,701 |
Total Patients
1,716
Total Services
1,941
Medicare Billing
$213,808
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 71 | $39,705 | $6,883 | 17.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 50 | 50 | $43,820 | $4,791 | 10.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 43 | 44 | $104,280 | $4,332 | 4.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 45 | 45 | $70,200 | $4,182 | 6.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $20,465 | $3,375 | 16.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 34 | $15,300 | $2,673 | 17.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 25 | 25 | $17,025 | $2,263 | 13.3% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 12 | 12 | $23,820 | $1,944 | 8.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 27 | $13,510 | $1,825 | 13.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 67 | 67 | $53,816 | $6,210 | 11.5% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 45 | 46 | $105,470 | $5,247 | 5.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 76 | $35,100 | $5,094 | 14.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 21 | 23 | $61,480 | $4,763 | 7.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 46 | $24,020 | $4,527 | 18.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $15,800 | $2,525 | 16.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 29 | 29 | $42,915 | $2,470 | 5.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 39 | $17,110 | $2,416 | 14.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $12,240 | $1,462 | 11.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $13,543 | $1,430 | 10.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 15 | $4,500 | $556.05 | 12.4% |
About Dr. Harish Guddati, M.D
Dr. Harish Guddati, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891040911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harish Guddati, M.D has received a total of $1,924 in payments from pharmaceutical and medical device companies, with $424.73 received in 2024. These payments were reported across 76 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,834).
As a Medicare-enrolled provider, Guddati has provided services to 1,716 Medicare beneficiaries, totaling 1,941 services with total Medicare billing of $213,808. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Bronx, NY
- Active Since 07/14/2012
- Last Updated 07/14/2012
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891040911
Products in Payments
- RINVOQ (Biological) $436.67
- ZEPOSIA (Drug) $292.80
- ENTYVIO (Biological) $284.59
- Epclusa (Drug) $250.00
- SKYRIZI (Biological) $183.89
- HUMIRA (Biological) $110.97
- ZEPATIER (Drug) $100.00
- ORCAPOD (Device) $40.00
- XIFAXAN (Drug) $33.58
- Mulpleta (Drug) $29.31
- VEGZELMA (Biological) $28.88
- OMVOH (Drug) $22.67
- AMJEVITA (Biological) $20.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Student in an Organized Health Care Education/Training Program $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Student in an Organized Health Care Education/Training Program $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Student in an Organized Health Care Education/Training Program $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Student in an Organized Health Care Education/Training Program $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Student in an Organized Health Care Education/Training Program $31,772
Dr. Dmitriy Nevelev, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,107
Student in an Organized Health Care Education/Training Program $30,107